Ali Tehrani
Founder at Student Biotechnology Network
Net worth: 3 M $ as of 30/04/2024
Network origin in Ali Tehrani first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of British Columbia
362
| College/University | Other Consumer Services | 362 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
34
| Subsidiary | Biotechnology | 34 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.
20
| Private Company | Biotechnology | 20 |
| Public Company | Pharmaceuticals: Major | 17 | |
Amplitude Ventures
 Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada.
14
| Holding Company | Investment Managers | 14 |
Creatus Biosciences, Inc.
 Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Creatus Biosciences, Inc. operates as an industrial biotechnology company specializing in yeast genetic design and development. The company was founded in 2014 and is headquartered in Vancouver, Canada.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann.
3
| Non-Profit Organization | Miscellaneous Commercial Services | 3 |
Premier's Technology Council
1
| Government | General Government | 1 |
Reverb Therapeutics
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ali Tehrani via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| McGill University | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Toronto | College/University | Masters Business Admin Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Chairman Director/Board Member | |
British Columbia Bar Association
 British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BioTalent Canada
 BioTalent Canada Miscellaneous Commercial ServicesCommercial Services BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Bast Fibre Technologies, Inc.
 Bast Fibre Technologies, Inc. TextilesProcess Industries Bast Fibre Technologies, Inc. engages in the production of plant-based natural fibres. The firm's process of making products include agronomics, decortication, wet processing, and fibre modification. Its products include baby wipes, personal care, household wipes, and commercial wipes. The company is headquartered in Victoria, Canada. | Textiles | Director/Board Member Chief Executive Officer Director/Board Member | |
| PROFOUND MEDICAL CORP. | Medical Specialties | Director/Board Member Director/Board Member Chief Executive Officer | |
| Université Laval | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Queen's University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
BioVectra, Inc.
 BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
adMare Bioinnovations
 adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Director/Board Member Chief Executive Officer | ||
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ability Biologics
 Ability Biologics BiotechnologyHealth Technology Ability Biologics, Inc. develops and manufactures immune modulating biotherapeutics and human therapeutic ready antibodies. The company is based in Montréal, Canada. It was founded by Giles Day and Jean-Philippe Bürckert, with Giles Day serving as the CEO since incorporation. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| KERMODE RESOURCES LTD. | Precious Metals | Director/Board Member Chief Executive Officer | |
| The Chinese University of Hong Kong | College/University | Masters Business Admin Masters Business Admin | |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Founder Director/Board Member | |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vancouver Aquarium
 Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Part of Herschend Family Entertainment Corp., Vancouver Aquarium operates an aquarium. The company is based in Vancouver, Canada. Vancouver Aquarium was acquired by Herschend Family Entertainment Corp. from Ocean Wise Conservation Association on April 15, 2021. The Canadian company was founded in 1951. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
BDC Capital, Inc.
 BDC Capital, Inc. Financial ConglomeratesFinance BDC Capital, Inc. provides investment services. It offers services to the corporate and private firm?s. The company is headquartered in Montreal, Canada. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Augurex Life Sciences Corp.
 Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member Founder | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Biotechnology | Director/Board Member Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Pennsylvania Law School | College/University | Graduate Degree Graduate Degree | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Giiant Pharma, Inc.
 Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Director/Board Member | |
BDC Venture Capital
 BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Private Equity Investor Private Equity Investor | |
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Investor | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| Simon Fraser University | College/University | Graduate Degree Undergraduate Degree |
Statistics
International
| Canada | 37 |
| United States | 14 |
| Hong Kong | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 9 |
| Finance | 5 |
| Process Industries | 2 |
Operational
| Director/Board Member | 352 |
| Corporate Officer/Principal | 120 |
| Independent Dir/Board Member | 71 |
| Undergraduate Degree | 67 |
| Chairman | 45 |
Most connected contacts
| Insiders | |
|---|---|
| Ken Galbraith | 30 |
| Maha Katabi | 28 |
| Louise Proulx | 25 |
| Jean-François Pariseau | 24 |
| Dion Madsen | 22 |
| Susan Mahony | 21 |
| Lota Zoth | 20 |
| Troy Cox | 19 |
| Gordon McCauley | 18 |
| J. Farris | 18 |
| Hollings Renton | 17 |
| Nancy Harrison | 17 |
| Arun Menawat | 16 |
| Mei Hing Chan | 15 |
| Mouane Sengsavang | 14 |
- Stock Market
- Insiders
- Ali Tehrani
- Company connections